![[Key Message] Venous Disease: Exploring the Link Between CVD and HD](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FiMPUnd7J_6A%2Fmqdefault.jpg)
11:15
11:15
9:54
6:59
7:31
![[Trailer] ACT-T2D Episode 5: Advantages of SPC: Enhancing Adherence and Outcomes](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FMw8PcpqkCqY%2Fmqdefault.jpg)
1:49
![[Ad] EOC × P2P](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FfO6099hIXps%2Fmqdefault.jpg)
0:18
![[EOC Webinar 3] Dual and Single Antiplatelet Therapy: When, Why and for How Long](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fu44WBsKGvp8%2Fmqdefault.jpg)
24:53
![[Trailer] ACT-T2D Episode 4: Adherence Challenges in Multimorbid Patients](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FJaQVtu-VRmg%2Fmqdefault.jpg)
1:42
![[Trailer] CMVD Series Episode 1 - Venous Health, the Link Between CVD & HD](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FcIoyF2O1XSE%2Fmqdefault.jpg)
0:53
![[Trailer] ACT-T2D Episode 3: Insights from ADA, AACE, EASD, and IDF](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FIDr3rIM7sw0%2Fmqdefault.jpg)
1:12
![[Trailer] ACT-T2D Episode 2: Current Perspectives of SUs in T2D](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FTd_-nQEb_Iw%2Fmqdefault.jpg)
1:16
![[STO Spotlight] Unedited Jill Feldman on Results from the phase 2 COCOON trial](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FX8XhP1U7wZc%2Fmqdefault.jpg)
5:14
![[STO Spotlight] Unedited Josh Sabari on PRO from the Beamion LUNG-1 trial](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FqeBKJOKVsF0%2Fmqdefault.jpg)
1:41
![[STO Spotlight] Unedited Terry L. Ng on REaCT-HOLD BMA](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FHVN7Ptt8Vg0%2Fmqdefault.jpg)
4:33
![[STO Spotlight] Unedited Dirk Arnold on OrigAMI-2 in left-sided RAS/BRAF wild-type mCRC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Frk5WmoTUz9g%2Fmqdefault.jpg)
1:43
![[STO Spotlight] Unedited Richard Finn on LEAP-002 in advanced hepatocellular carcinoma](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FQqvjWqL6Aes%2Fmqdefault.jpg)
2:18
![[STO Spotlight] Unedited Joel Hecht on OrigAMI-3 in RAS/BRAF wild-type colorectal cancer](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FhDlvDtUxW_Q%2Fmqdefault.jpg)
4:37
![[Ad] ACT T2D](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FN7jAO72te90%2Fmqdefault.jpg)
0:12
![[Trailer] ACT-T2D Episode #1: Early optimal glycemic control to prevent T2D complications](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FCvMjHXyZ-zA%2Fmqdefault.jpg)
1:14
![[STO Spotlight] Unedited Paolo Tarantino on Immune, Genetic, TILs as predictors for TNBC outcomes](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F-RD5VjFqgUw%2Fmqdefault.jpg)
2:35
![[STO Spotlight] Unedited Paolo Tarantino on DATO-Base, a breast cancer brain metastases Ph II study](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FyuDuZRh0XqE%2Fmqdefault.jpg)
1:29
![[STO Spotlight] Unedited Manmeet Ahluwalia discusses LIMITLESS - a trial in NSCLC brain mets](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FmYpGLu-To1o%2Fmqdefault.jpg)
5:15
![[STO Spotlight] Unedited Manmeet Ahluwalia on a multi-center basket trial of Nivo/Ipi in brain mets](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F5wF6Wf6ALd4%2Fmqdefault.jpg)
6:12
![[STO Spotlight] Unedited Jean Fan on Ph1 for TT-00973-MS, an AXL inhibitor in solid tumor patients](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FyjFpFE5wVgo%2Fmqdefault.jpg)
3:34
![[STO Spotlight] Unedited Raymond Osarogiagbon on disparity in outcomes for targeted therapy in NSCLC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fwu_XfZriGP8%2Fmqdefault.jpg)
6:42
![[STO Spotlight] Unedited Ruth O'Regan on Assessment of OFS-containing adjuvant endocrine therapy](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fu7IWQPox2vk%2Fmqdefault.jpg)
1:37
![[STO Spotlight] Unedited Jacob Sands on a new DLL3-targeted autologous CAR-T cell therapy in SCLC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FnucuuwSKALo%2Fmqdefault.jpg)
2:59
![[STO Spotlight] Unedited Heather McArthur on a Ph3 adjuvant use of Saci plus Pem in TNBc](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Ff3k4-WrMOCM%2Fmqdefault.jpg)
3:16
![[STO Spotlight] Unedited Jared Weiss on PDS0101&pembrolizumab boost HPV+head-neck cancer survival](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F_XjIYGv_D4g%2Fmqdefault.jpg)
1:01
![[STO Spotlight] Unedited Ben Garmezy on two-dose escalation cohorts of Ph 1b STELLAR 002 study](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FPkXEvgjh37Y%2Fmqdefault.jpg)
5:46
![[STO Spotlight] Unedited Ronan Kelly on Falcon Registry: Early Cancer Detection Evidence](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FOOdnxTXITl8%2Fmqdefault.jpg)
5:20
![[STO Spotlight] Unedited Breadley McGregor on a phase II study of Cabo/Nivo/Ipi in advanced RCC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FJKtIrfwwyiU%2Fmqdefault.jpg)
3:36
![[STO Spotlight] Unedited Stephanie Graff on Adjuvant WIDER: Ph3b of ribociclib+HR in HR+/HER2- BC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FATFESuK1eHQ%2Fmqdefault.jpg)
6:47
![[STO Spotlight] Unedited Paulo Siquiera on Amaral on safety of belzutifan in VHL](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F_BlH1A-Uhuw%2Fmqdefault.jpg)
3:19
![[STO Spotlight] Unedited Alicia Morgans on Phase III trial - ARASTEP in Prostate Cancer](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F-s9OVBigJQQ%2Fmqdefault.jpg)
1:43
![[STO Spotlight] Unedited David Spigel on High Risk by Assay Adjuvant Early Stage NSCLC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FloZ4Zpgy9gI%2Fmqdefault.jpg)
3:09
![[STO Spotlight] Unedited Jason Luke on SUPRAME: Ph3 IMA203 in advanced cutaneous melanoma (unedited)](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FHH9I1BAbDRs%2Fmqdefault.jpg)
4:15
![[STO Spotlight] Unedited J. Strickler on Ph3 Temab-A vs. TAS-102 + Bev in refractory mCRC patients](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fmc_wq7MDt14%2Fmqdefault.jpg)
4:59
![[STO Spotlight] Unedited Michael Postow on predicting IO response in advanced solid tumors](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F7JOTn-iXMJs%2Fmqdefault.jpg)
6:28
![[STO Spotlight] Unedited Neil Iyengar on exercise as first-line therapy for HR + breast cancer](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fcdbvc5sKuq4%2Fmqdefault.jpg)
5:02
![[STO Spotlight] Unedited Stephen Liu on OSE2101 vaccine in Ph 3 for metastatic NSCL](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FVnhJBIT0LOM%2Fmqdefault.jpg)
2:05
![[STO Spotlight] Unedited Priyanka Sharma on ImPrintTN signature and TNBC survival outcomes](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FbcRbFUorWfA%2Fmqdefault.jpg)
3:10
![[STO Spotlight] Unedited Paulo Siqueira on Amaral on Efficacy of treatment after therapy in nccRCC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FOozvAyysCl0%2Fmqdefault.jpg)
3:07
![[Trailer] SEASON FINALE - EP World Live Series Episode #8 on Tue, 15th Jul 25, 1:00pm to 2:30pm CEST](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FON0FLhmUTKc%2Fmqdefault.jpg)
4:34
![[STO Spotlight] Unedited Cristiane Bergerot on age-specific unmet needs in older cancer patients](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FYxZbnyO8CT0%2Fmqdefault.jpg)
1:59
![[Trailer] EP World Live Series Episode #7 on Tuesday, 1st July 2025, 1:00pm to 2:30pm CEST](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F3n2ymD8vNHU%2Fmqdefault.jpg)
4:50
![[STO Spotlight] Unedited Michael Ong on TRIPLE-SWITCH in mCSPC](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F0t5pePg9Zp8%2Fmqdefault.jpg)
1:48
![[STO Spotlight] Unedited Joyce O'Shaughnessy on update to safety from EMBER-3](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2F-lHgG1ij36s%2Fmqdefault.jpg)
11:22
![[STO Spotlight] Unedited Sarah Sammons on update to ReDiscover trial](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fj7-KLyXycRg%2Fmqdefault.jpg)
6:31
![[STO Spotlight] Unedited Marcia Brose on larotrectinib in patients w/ TRK fusion thyroid carcinoma](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FR23S_d5Q3NM%2Fmqdefault.jpg)
2:46
![[Trailer] EP World Live Series Episode #6 on Tuesday, 17th Jun 2025, 1:00pm to 3:00pm CEST](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FUfSk6oGwa6Y%2Fmqdefault.jpg)
4:58
![[Trailer] EP World Live Series Episode #5 on Tuesday, 27th May 2025, 1:00pm to 3:00pm CEST](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fbk59GhqlfcE%2Fmqdefault.jpg)
5:32
![[Trailer] Translational Medicine Academy World Channel (TMA)](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FJ2d6Y-Q7SnU%2Fmqdefault.jpg)
1:04
![[Trailer] Short Takes in Oncology powered by P2P](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2Fvd4eqraMoZg%2Fmqdefault.jpg)
0:43
0:36
0:54
2:23
4:54
0:54
![[Trailer] EP World Live Series Episode #4 on Tuesday, 25th Feb 2025, 1:00pm to 3:30pm CEST](/thumb?url=http%3A%2F%2Finvidious%3A3000%2Fvi%2FDfKN0BOdXLU%2Fmqdefault.jpg)
6:17